During a disease outbreak, an agnostic diagnostic (a diagnostic that can detect any pathogen) would be a powerful tool to aid the public health response from day one. Next-generation sequencing (NGS) technologies can identify any pathogen present in a sample — including emerging pathogens. DRIVe is supporting innovation in metagenomic NGS technologies to bring this much-needed capability closer to commercialization as an agnostic diagnostic for future pandemic preparation. Learn more and submit by May 15th.